Plain-English translation of NCT07233993 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Cervical dystonia is a condition where neck muscles contract involuntarily, causing abnormal head postures, pain, and tremor. The standard treatment is botulinum toxin type A injections into the neck muscles every 12 to 16 weeks. This trial is testing whether using ultrasound to visualize the muscles during injection—rather than relying on the doctor's touch and anatomical landmarks alone—leads to better results and fewer side effects.
While botulinum toxin type A is an established, safe treatment for cervical dystonia, how well it works depends heavily on whether the injection hits the right muscle. Ultrasound allows doctors to see the muscles in real time, which may improve accuracy, but this hasn't been rigorously tested in a large, well-designed study yet.
You likely qualify if…
You likely don't qualify if…
You will receive botulinum toxin injections into your neck muscles, but the method will vary: some participants will receive injections guided by real-time ultrasound imaging, while others will receive injections using the traditional method based on anatomical landmarks (with the ultrasound machine present but screen off, so neither you nor the doctor assessing your results will know which method was used). This is a crossover study, meaning you may receive both types of injections at different visits over the course of the trial to compare outcomes.
AI-generated summary from trial data · Sep 2, 2026 · Not medical advice
Italy